XCDS
2.12.2020 10:36:10 CET | Business Wire | Press release
Shaping the future of teamwork is a difficult challenge and Collabio® Spaces by XCDS is ready to take it head on. After several years of stealth mode development, the team which includes former QuickOffice™ engineers released their alternative view on collaboration around documents and co-authoring. Their software works with the majority of popular office document formats and enables real time collaboration even without Internet connection and clouds. Collabio Spaces allows you to share access to your documents whilst keeping them exceptionally and solely on your private mobile or desktop device.
The next step in the app's evolution is taking part in Web Summit — the "best technology conference on the planet ", according to Forbes. Collabio Spaces team will join 100.000+ attendees, 800+ speakers and 2500+ startups on December 2-4, 2020.
The team will speak about technologies behind cloudless collaboration and real time co-authoring, present our product and meet with partners.
"We'll join Web Summit to share our ideas and get feedback from the most innovative community in our world. This is the place where the future is shaped and we'd like to place our stake in this process, " said Andy Webb, CEO.
At Web Summit, the Collabio Spaces team will hold two roundtables :
-
"Co-authoring documents. What’s good and what’s still missing"
—15:00 - 15:45 (UK Time) on Wednesday, December 2, 2020.
You'll learn how to improve your teamwork on documents and why you should pay attention to that, we will speak of which document co-editing issues are left to be resolved and how they may be fixed. Also, you'll get a bunch of useful tips for effective co-authoring, which will boost your team's productivity!
If you write or review documents, lead teams of authors and aim to achieve results at tough deadlines or want to raise the quality of final documents, we expect this roundtable will be valuable for you!
-
"Under the hood of cloudless collaboration"
— 14:00 - 15:45 (UK Time) on Thursday, December 3, 2020.
Collabio Spaces' tech team will share their hands-on experience on enabling team collaboration in a simple WiFi network. You will find out how to make an iPhone the nexus point of documents co-editing without involving any external servers. We'll discuss the magic behind this cloudless technology and the model that we fitted into the tough requirements of mobile device computing power!
Are you a tech geek or just take interest in peer-to-peer technologies and mobile applications? We're waiting for you at this roundtable!
To learn more about the App and our plans for Web Summit 2020, visit the official website and feel free to ask us any questions on socials or via email.
XCDS is a software development company that creates user-friendly and efficient office software for iOS, macOS, Windows and Linux devices, and now — our new innovative and convenient iOS app.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201130005090/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Splio Enters a New Phase of Its Regional Development in Southern Europe19.5.2026 09:00:00 CEST | Press release
As consumers integrate AI into their everyday web usage, Splio is strengthening its presence in Barcelona to help companies across the region make CRM a central lever in the age of agentic commerce Splio is strengthening its presence in Barcelona, which is set to play the role of a second headquarters, to drive its development across Southern Europe.Splio is reinforcing governance, teams and resources deployed in the region.With its AI-first CRM, Splio aims to help companies from retail to travel strengthen the business contribution of CRM. A few months after launching its AI-first CRM, Splio is entering a new phase of its development in Southern Europe. Already established for more than 12 years in Spain, Portugal and Italy, the company has chosen to invest further in the region, convinced that it combines economic potential with rapidly evolving digital usage. Antoine Parizot, Splio’s co-CEO, is relocating to Barcelona, where the company’s historic office is based. At the same time,
KfW, Germany’s largest national promotional bank, future-proofs regulatory reporting, by migrating to Regnology Reporting Hub (RRH)19.5.2026 08:33:00 CEST | Press release
Longstanding client transitions to the next-generation RRH solution, delivered on Regnology’s Rcloud architecture Regnology, a leading provider at the intersection of regulatory, risk, and supervisory technology, today announced that KfW Bankengruppe (KfW) is advancing its long-term partnership with the company by electing to migrate to the next-generation Regulatory Reporting Hub (RRH). The solution will be delivered as a cloud-native service on Rcloud, Regnology’s high-performance cloud architecture layer. This strategic move to the modern RRH platform future-proofs the mission-critical reporting functions for one of the world's leading promotional banks. Headquartered in Frankfurt am Main, KfW is a public‑law institution dedicated to supporting sustainable economic, social and ecological development in Germany, across Europe and globally. Regnology’s foresight led to the 2023 launch of Rcloud, its state-of-the-art architecture layer built on Google Cloud, enabling next‑generation so
ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth19.5.2026 08:00:00 CEST | Press release
ATB Therapeutics (“ATB” or the “Company”), a biopharmaceutical company advancing next-generation antibody-based therapies for oncology and immunology, today announced the appointment of Mark Throsby, PhD, as Chief Executive Officer. The leadership transition marks an important milestone as the Company continues its evolution from a startup into a development-stage biopharmaceutical company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513198633/en/ ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth Mark Throsby has served as Executive Chairman and Chief Scientific Officer since 2024, during which time he supported the Company’s growth, including the successful closing of its Series A financing, the expansion of the scientific team, and the advancement of its therapeutic programs. In his new role, he will lead ATB’s strategy and senior leadership team as the Company prepares to enter clinical deve
TREASoURcE Shows How Circular Economy Solutions Can Move Beyond Pilots Across Sectors and Regions19.5.2026 07:00:00 CEST | Press release
Across Europe, many circular economy solutions struggle to move beyond isolated pilots and into real-world deployment at scale. New approaches are needed that combine technical feasibility, market relevance and citizen engagement, while remaining adaptable to local contexts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260518914041/en/ TREASoURcE addressed circular economy challenges across energy, plastics and biobased side streams, combining technical solutions with stakeholder and citizen engagement. The EU-funded TREASoURcE project provides evidence that systemic, citizen-engaged circular economy solutions can be developed, tested and prepared for replication across regions. Using a common regional approach, the project combined real-life demonstrations, cross-value chain collaboration and early consideration of transferability to translate circular economy concepts into practical solutions in the fields of energy, mat
Azafaros Strengthens Leadership Team With Appointment of Amy Sullivan as Chief Financial Officer19.5.2026 07:00:00 CEST | Press release
Experienced biotech finance leader with over 30 years’ experience in capital markets and strategyProven track record in fundraising, M&A and company transformationCompany is currently running two pivotal Phase 3 studies with nizubaglustat in GM1/ GM2 gangliosidoses and Niemann-Pick type C disease Azafaros, a private company building a portfolio to become a leader in Lysosomal Storage Disorders and focused on addressing neurological symptoms, today announced that Amy Sullivan has joined the company as Chief Financial Officer. Ms. Sullivan brings more than 30 years’ experience in the life sciences sector, with expertise in capital raising, corporate strategy and communications. She joins Azafaros from IO Biotech, where she served as Chief Financial Officer. “Amy is a highly accomplished financial leader with a strong track record of supporting growth-stage biotech companies,” said Stefano Portolano, Chief Executive Officer at Azafaros. “Her expertise in financing, strategic positioning a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom